Join LCI at CPHI Americas 2026 (Booth #433) to discuss continuous manufacturing, extrusion, spheronization, and thin film evaporation. Discover how our engineering expertise and process testing capabilities support pharmaceutical manufacturers, CDMOs, and process engineers with scalable processing technologies.
From June 2–4, 2026, pharmaceutical manufacturers, CDMOs, process engineers, and technology leaders from across the industry will gather at the Pennsylvania Convention Center in Philadelphia for CPHI Americas 2026, one of the industry’s leading events for pharmaceutical manufacturing and processing innovation.
As manufacturers navigate evolving regulatory expectations, containment requirements, process efficiency goals, and increasing production complexity, the need for reliable and scalable process technologies has never been greater.
This year, LCI Corporation will be exhibiting at Booth #433, showcasing pharmaceutical processing solutions engineered to support modern manufacturing environments through improved process control, operational flexibility, and long-term performance.
LCI Corporation, part of the Nederman Group, has decades of experience supporting pharmaceutical manufacturers with advanced powder processing and evaporation technologies.
Headquartered in Charlotte, North Carolina, LCI designs and engineers solutions for pharmaceutical applications where consistency and process reliability are critical. Through a combination of application expertise, engineering support, and process testing capabilities, LCI works closely with manufacturers to help optimize production performance across a wide range of pharmaceutical operations.
A key part of this approach is LCI’s fully equipped Test Center, where customers can evaluate equipment performance and validate process parameters at laboratory and pilot scale before transitioning to full-scale production. For pharmaceutical manufacturers operating in highly regulated environments, this provides valuable insight and confidence during process development and scale-up.
During CPHI Americas 2026, attendees visiting Booth #433 will have the opportunity to discuss a range of pharmaceutical processing technologies designed to support efficient, compliant, and scalable manufacturing operations.
LCI’s powder processing technologies support pharmaceutical production applications ranging from granulation through pellet formation and material handling.
Featured solutions include:
These technologies are designed to help manufacturers improve process consistency, production efficiency, and operational control across oral solid dosage applications.
LCI also provides evaporation and drying technologies developed for challenging pharmaceutical processing applications, particularly those involving heat-sensitive or high-viscosity materials.
Solutions include:
These systems support pharmaceutical manufacturers requiring precise thermal control, reliable solvent recovery, and efficient processing of sensitive compounds.
LCI’s Test Center capabilities allow pharmaceutical manufacturers to evaluate process performance prior to production-scale implementation.
Laboratory and pilot-scale trials support:
This testing approach helps reduce uncertainty during scale-up while supporting more informed process and equipment decisions.
Join LCI at Booth #433 from June 2–4, 2026, at the Pennsylvania Convention Center in Philadelphia for technical discussions on real-world pharmaceutical manufacturing applications and process improvement.
At Booth #433, attendees can:
Whether you are evaluating new process technologies, optimizing existing operations, or planning future manufacturing investments, LCI’s team will be available to discuss solutions tailored to your production requirements.
We look forward to connecting with pharmaceutical manufacturing professionals and discussing the technologies shaping the future of pharmaceutical processing.